The evidence of a macrophage barrier in the xenotransplantation of human hematopoietic stem cells to severely immunodeficient rats
The evidence of a macrophage barrier in the xenotransplantation of human hematopoietic stem cells to severely immunodeficient rats
复制标题
人类造血干细胞异种移植至严重免疫缺陷大鼠中巨噬细胞屏障的证据
DOI:
10.1111/xen.12702
复制
发表时间:
2021
影响因子:
3.9
通讯作者:
Oda Tatsuya
中科院分区:
文献类型:
--
作者:
Furuya Kinji;Zheng Yun-Wen;Ge Jian-Yun;Zhang Ludi;Furuta Tomoaki;Liang Chen;Abe Haruna;Yagi Hiroya;Hamada Hiromi;Isoda Hiroko;Hui Lijian;Ohkohchi Nobuhiro;Oda Tatsuya
BackgroundThe human‐to‐rat hematopoietic stem cell transplantation (HSCT) model is rare, unlike its human‐to‐mouse counterpart. The rat models are desired, especially in areas of physiology, toxicology, and pharmacology. In addition to lymphocytes, macrophages are also considered to be important for xenotransplantation. We generated a rat xenotransplantation model to prove the role of macrophages as a xenotransplantation barrier.MethodsImmunodeficiency in SRG rats, which are Sprague–Dawley (SD) rats lackingRag2andIl2rg, was confirmed by flow cytometry and spleen immunostaining. Human umbilical cord blood was collected after scheduled cesarean section at the University of Tsukuba Hospital. Cord blood mononuclear cells (CB‐MNCs) were transplanted into the SRG rats administered several injections of clodronate liposome (CL), which cause macrophage depletion. Survival of human cells was observed by flow cytometry. Rat macrophage phagocytosis assay was performed to check the species‐specific effects of rat macrophages on injected human/rat blood cells.ResultsSRG rats were deficient in T/B/NK cells. Without CL pretreatment, human CB‐MNCs were removed from SRG rats within 7 hours after transplantation. The rats pretreated with CL could survive after transplantation. Prolonged survival for more than 4 weeks was observed only following a one‐time CL injection. Rat macrophages had a species‐specific potential for the phagocytosis of human blood cells in vivo.ConclusionIn human‐to‐rat HSCT, the short period of early macrophage control, leading to macrophage immunotolerance, is important for engraftment. The generated model can be useful for the creation of future xenotransplantation models or other clinical research.